节点文献

放射性药物与Egr-Endostatin重组质粒的协同抑瘤作用

Radioactive Drugs and Egr-endostatin Synergistic Antitumor Effect

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李勇高慧棋马铎徐岩松孙淑芳杨志杰

【Author】 LI Yong,GAO Hui-qi,MA Duo,et al.(Department of PET-CT,the Affiliated First hospital of Harbin Medical University,Harbin 150001,China)

【机构】 哈尔滨医科大学附属第一医院PET-CT室

【摘要】 目的探讨Egr-内皮抑素基因联合放射性药物-胶体32P对于大鼠肝癌的抑制效果。方法经局部引入基因重组质粒及胶体32P后于,7 d1、4 d2、1 d分别测肝癌的生长率,第21d测定肝癌微血管密度(MVD)、肿瘤细胞凋亡指数(AI)等指标的变化。结果各干预组的肿瘤体积生长率、MVD、AI与对照组指标相比均具有统计学差异,P均<0.05-0.01,在所有干预组中,32P+Egr-Endostatin组的抑瘤效果最好,P均<0.05-0.01。肝癌生长率方面,第7 d-14d,32P干预组与单纯内皮抑素基因组、Egr-内皮抑素基因组相比抑瘤效果相近,P>0.05;但到达21 d时,胶体32P干预组治疗效果则明显下降。基因联合胶体32P的干预组效果均好于其它干预组,P<0.05-0.01。MVD方面,32P组与其它干预组比较具有统计学差异,P<0.01。AI指标,其他干预组与32P组比较具有差异,P<0.05。结论 32P联合Egr-Endostatin基因协同抑瘤,可以发挥放射性药物的照射作用,Eg-1的辐射诱导增强作用及Endostatin基因的抑制肿瘤新生血管的三重作用,疗效最为确切。

【Abstract】 Objective To investigate the antitumor effect of EgrEndostatin gene combined with radioactive drug-colloidal 32P inhibitory on the rat liver.Methods After gene and colloidal 32 P were injected into liver cancer,the growth rate of liver cancer were measured at 7 d,14 d,21 d.Microvessel density determination(MVD)and apoptosis index(AI) were be measured at 21 d.Results Compared with the control the indexs in the treatment groups had significant difference index(P<0.05-0.01).The inhibitory effect of 32 P+ Egr-Endostatin is the best(P<0.01).In the term of liver cancer growth rate,there are not significant difference between the 32 P group,Endostatin gene and Egr-Endostatin gene group in antitumor effect at 7 d-14 d,(P>0.05);But at 21 d,the treatment effect of 32 P group is clearly down.In terms of MVD,compared with the control group the treatment group has obvious statistical difference(P<0.01);compared with the other treatment group,32P group has statistical difference(P<0.01);32 P+Endostatin group has statistical comparing with other groups(P<0.01).In terms of AI index,the control group has statistical difference comparing with treatment groups(P<0.01);32P group also has difference comparing with Endostatin group and Egr-Endostatin group(P<0.05);AI index of 32 P+Endostatin group and 32 P+Egr-Endostatin is better than other treatment groups(P<0.05-0.01).Conclusion Colloidal 32 P combining Egr-Endostatin gene plays the important role in treating liver cancer.32P can create the radiation function,Egr-1 can induce expression enhancement of Endostatin and the Endostatin Gene can inhibit liver tumor angiogenesis.Therefore the whole effect of the three factors can manifestly decrease the liver cancer growing.

【关键词】 基因治疗肝肿瘤实验性疾病模型动物大鼠Wistar
【Key words】 Gene therapyLiver neoplasmsexperimentalDisease modelsanimalRatsWistar
【基金】 黑龙江省教育厅资助项目(11521194);黑龙江省卫生厅资助项目(2007-234)
  • 【文献出处】 中国实验诊断学 ,Chinese Journal of Laboratory Diagnosis , 编辑部邮箱 ,2010年06期
  • 【分类号】R730.5
  • 【被引频次】1
  • 【下载频次】46
节点文献中: 

本文链接的文献网络图示:

本文的引文网络